Kidswell Bio Corporation
- Biotech or pharma, therapeutic R&D
Founded in 2001, Kidswell Bio specializes in the development of biosimilars (BS).Our core strength lies in our deep experience in cell line development and CMC management, cultivated through close collaboration with CDMO networks. With several first-to-market BS products successfully launched, we are now looking to expand our pipeline through global partnerships in biosimilar development and commercialization.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}